Report Code: A12660 | Nov 2023 | Pages: NA | ||
Tables: NA | Charts: NA |
|
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Intranasal Migraine Drugs Market
Request Now !Intranasal drugs are an important part of migraine treatment. Migraine headache attacks are prevented by using these medicines. It assists in reducing headache pain and other symptoms like sensitivity to sound or light. Timely treatment enables a patient to get back to their normal routine shortly and may lessen your requirement for different pain medications. Migraine occurrences are not be prevented by this medication. New product launches by key manufacturers, rising R&D activities, and quick drug approvals by regulatory bodies such as the U.S. Food and Drug Administration for chronic and acute migraines have anticipated providing profitable opportunities in the coming years.
COVID-19 Impact analysis
COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome corona virus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the intranasal migraine drugs market.
Top Impacting Factors
Intranasal migraine drugs Market Trends
New product launches to flourish the market
In January 2021, Impel Neuro Pharma received U.S. Food and Drug Administration (FDA) approval for the new drug application for INP104, for the acute treatment of migraine headaches.
In March 2021, Cipla received U.S FDA approval to treat migraine attacks for a nasal spray.
In June 2020, Tonix Pharmaceuticals acquired pain and non-addictive migraine treatment programs of Trigemina Inc. and will also acquire the license of TNX-1900 intranasal oxytocin. It has the potential to treat craniofacial pain and migraine.
In January 2019, Dr. Reddy's Laboratories received the US Food and Drug Administration (FDA) approval for a sumatriptan nasal splash to provide the intense therapy for headache.
Key Benefits of the Report
Questions answered in the intranasal migraine drugs Report
Intranasal migraine drugs Market Report Highlights
Aspects | Details |
---|---|
By Therapeutic Class |
|
By Indication |
|
By Range |
|
By Distribution Channel |
|
By Region |
|
Key Market Players | Neuro Pharma, Roche, Sanofi, Novartis AG, Baxter International Inc., Merck, Lockhart ltd, Pfizer Inc., Dr. Reddy’s Laboratories, Aegis Therapeutics LLC |
Start reading.
This Report and over 66,804+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers